| scholarly article | Q13442814 |
| P50 | author | Karin E. Bornfeldt | Q87887672 |
| Farah Kramer | Q125299327 | ||
| P2093 | author name string | Kazuhiro Oka | |
| Stephen M Schwartz | |||
| Lawrence Chan | |||
| Shelley Barnhart | |||
| Fredrik Johansson | |||
| Michael E Rosenfeld | |||
| Bardia Askari | |||
| Patti Polinsky | |||
| Erin D MacDougall | |||
| Rebecca Varon | |||
| P2860 | cites work | The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor | Q28281141 |
| Intensive lifestyle changes for reversal of coronary heart disease | Q28292247 | ||
| A major role for VCAM-1, but not ICAM-1, in early atherosclerosis | Q28365883 | ||
| Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery | Q29615235 | ||
| Intensive versus moderate lipid lowering with statins after acute coronary syndromes | Q29619716 | ||
| Atherosclerotic plaque rupture in the apolipoprotein E knockout mouse | Q31886473 | ||
| Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor | Q32129558 | ||
| Nonoxidative modifications of lipoproteins in atherogenesis | Q33711770 | ||
| Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial | Q33940282 | ||
| Hypertriglyceridemia and the fibrate trials | Q34086718 | ||
| Macrophage expression of active MMP-9 induces acute plaque disruption in apoE-deficient mice | Q34236802 | ||
| Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit | Q34248584 | ||
| A risk factor for atherosclerosis: triglyceride-rich lipoproteins. | Q34496762 | ||
| Rupture of the atherosclerotic plaque: does a good animal model exist? | Q35077352 | ||
| From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II. | Q35558849 | ||
| Pathologic assessment of the vulnerable human coronary plaque | Q35583211 | ||
| Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma | Q35833674 | ||
| Lipid lowering therapy in atherosclerosis | Q36110619 | ||
| Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage | Q36204124 | ||
| Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a). | Q36476141 | ||
| Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques | Q37416056 | ||
| Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions | Q37486465 | ||
| Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis | Q37548758 | ||
| Diet-induced atherosclerosis and experimental hypertension in stumptail Macaques (Macaca Arctoides) Effects of antihypertensive drugs and a non-atherogenic diet in the evolution of lesions | Q39605272 | ||
| Overview of studies on regression of atherosclerosis. | Q40309023 | ||
| Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice | Q40506477 | ||
| In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression | Q41724329 | ||
| Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content | Q42578006 | ||
| The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression | Q43688410 | ||
| Dramatic remodeling of advanced atherosclerotic plaques of the apolipoprotein E-deficient mouse in a novel transplantation model. | Q43726746 | ||
| Acute regression of advanced and retardation of early aortic atheroma in immunocompetent apolipoprotein-E (apoE) deficient mice by administration of a second generation [E1(-), E3(-), polymerase(-)] adenovirus vector expressing human apoE. | Q43843334 | ||
| Characteristics of intact and ruptured atherosclerotic plaques in brachiocephalic arteries of apolipoprotein E knockout mice | Q43989979 | ||
| ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness | Q44179188 | ||
| Relation Between Progression and Regression of Atherosclerotic Left Main Coronary Artery Disease and Serum Cholesterol Levels as Assessed With Serial Long-Term (≥12 Months) Follow-Up Intravascular Ultrasound | Q44659628 | ||
| Intraplaque hemorrhage and progression of coronary atheroma | Q44688413 | ||
| Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial | Q44783935 | ||
| Serial studies of mouse atherosclerosis by in vivo magnetic resonance imaging detect lesion regression after correction of dyslipidemia. | Q44980739 | ||
| Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia | Q44990101 | ||
| Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels | Q45182834 | ||
| Regression of advanced atherosclerosis in swine | Q45234175 | ||
| Effects of diabetes and CETP expression on diet-induced atherosclerosis in LDL receptor-deficient mice. | Q45241682 | ||
| Intensive lipid lowering with atorvastatin in patients with stable coronary disease | Q45310626 | ||
| Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques: a high-resolution magnetic resonance imaging study | Q46505779 | ||
| Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. | Q47924135 | ||
| Dietary lipid lowering reduces tissue factor expression in rabbit atheroma. | Q52536357 | ||
| Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta | Q56986958 | ||
| A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association | Q57222067 | ||
| Increased vulnerability of pre-existing atherosclerosis in ApoE-deficient mice following adenovirus-mediated Fas ligand gene transfer | Q64378618 | ||
| Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice | Q64381202 | ||
| Rapid regression of atherosclerosis induced by liver-directed gene transfer of ApoE in ApoE-deficient mice | Q64381279 | ||
| A study of atherosclerosis regression in Macaca mulatta. IV. Changes in coronary arteries from animals with atherosclerosis induced for 19 months and then regressed for 24 or 48 months at plasma cholesterol concentrations of 300 or 200 mg/dl | Q70793807 | ||
| Sequential morphologic studies of regression of advanced atherosclerosis | Q71853347 | ||
| Long-term induction and regression of diet-induced atherosclerotic lesions in rhesus monkeys. II. Morphometric evaluation of lesions by light microscopy in coronary and carotid arteries | Q72858565 | ||
| Intimal deposition of functional von Willebrand factor in atherogenesis | Q73083067 | ||
| Advanced atherosclerotic lesions in the innominate artery of the ApoE knockout mouse | Q73295343 | ||
| Cell composition, replication, and apoptosis in atherosclerotic plaques after 6 months of cholesterol withdrawal | Q77167596 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 2064-2073 | |
| P577 | publication date | 2006-06-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficien | |
| P478 | volume | 168 |
| Q52684469 | A Novel Strategy to Prevent Advanced Atherosclerosis and Lower Blood Glucose in a Mouse Model of Metabolic Syndrome. |
| Q33332589 | An inducible and reversible mouse genetic rescue system |
| Q38218391 | Animal models of atherosclerosis and magnetic resonance imaging for monitoring plaque progression |
| Q33926011 | Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice. |
| Q40048835 | Down-regulation of single-stranded DNA-binding protein 1 expression induced by HCMV infection promotes lipid accumulation in cells |
| Q33361587 | HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study |
| Q91795685 | Increased apolipoprotein C3 drives cardiovascular risk in type 1 diabetes |
| Q37262945 | Inducible ApoE gene repair in hypomorphic ApoE mice deficient in the low-density lipoprotein receptor promotes atheroma stabilization with a human-like lipoprotein profile |
| Q36687078 | Interleukin-7 induces recruitment of monocytes/macrophages to endothelium |
| Q36602809 | Macrophage Phenotype and Function in Different Stages of Atherosclerosis |
| Q49026058 | Macrophages and lipid metabolism |
| Q89967822 | Monocytes and Macrophages as Protagonists in Vascular Complications of Diabetes |
| Q36766171 | Mouse models for studies of cardiovascular complications of type 1 diabetes |
| Q36063184 | Myeloid Cell Prostaglandin E2 Receptor EP4 Modulates Cytokine Production but Not Atherogenesis in a Mouse Model of Type 1 Diabetes |
| Q50102325 | Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor |
| Q36456886 | Paraoxonase 1 gene transfer lowers vascular oxidative stress and improves vasomotor function in apolipoprotein E-deficient mice with pre-existing atherosclerosis. |
| Q37108304 | Progression and disruption of advanced atherosclerotic plaques in murine models |
| Q42023940 | Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies |
| Q89013999 | Smooth muscle glucose metabolism promotes monocyte recruitment and atherosclerosis in a mouse model of metabolic syndrome |
| Q55280703 | Study of the association of 17 lipid-related gene polymorphisms with coronary heart disease. |
| Q42818053 | The Therapeutic Role of Very Low-Density Lipoprotein Receptor Gene in Hyperlipidemia in Type 2 Diabetic Rats |
| Q36883079 | Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice. |
| Q39882687 | Up-regulation of VLDL receptor expression and its signaling pathway induced by VLDL and beta-VLDL. |
Search more.